Susquehanna Maintains Negative on RXO, Lowers Price Target to $13
Portfolio Pulse from Benzinga Newsdesk
Susquehanna analyst Bascome Majors maintains a negative outlook on RXO (NYSE:RXO) and has lowered the price target from $14 to $13.
October 03, 2023 | 6:40 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Susquehanna analyst Bascome Majors has lowered the price target for RXO from $14 to $13 and maintains a negative outlook.
The lowering of the price target by a prominent analyst like Bascome Majors indicates a lack of confidence in the stock's performance. This could potentially lead to a decrease in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100